These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 33984350

  • 1. Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: Proposed modification in the current UICC/AJCC staging system.
    Wang XY, Zhu SY, Wu WJ, Li HJ, Li J, Lin XF, Li L, Liu LZ.
    Radiother Oncol; 2021 Jul; 160():221-227. PubMed ID: 33984350
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL, Wang Y, Liang SB, He SS, Chen DM, Chen HY, Lu LX, Chen Y.
    BMC Cancer; 2018 May 29; 18(1):606. PubMed ID: 29843648
    [Abstract] [Full Text] [Related]

  • 3. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
    Huang CL, Guo R, Li JY, Xu C, Mao YP, Tian L, Lin AH, Sun Y, Ma J, Tang LL.
    Eur Radiol; 2020 Feb 29; 30(2):816-822. PubMed ID: 31650266
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Kang M, Zhou P, Liao X, Xu M, Wang R.
    Oral Oncol; 2017 Dec 29; 75():100-105. PubMed ID: 29224805
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
    Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, Ma J.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1090-7. PubMed ID: 21864993
    [Abstract] [Full Text] [Related]

  • 6. Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Cao C, Jiang F, Jin Q, Jin T, Huang S, Hu Q, Chen Y, Piao Y, Hua Y, Feng X, Chen X.
    Cancer Res Treat; 2019 Jan 01; 51(1):73-79. PubMed ID: 29510615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective study.
    Liang SB, Chen LS, Chen HY, Yang XL, Wang DH, Cui CY, Xie CB, Liu LZ, Xu XY.
    Radiother Oncol; 2021 Mar 01; 156():113-119. PubMed ID: 33310007
    [Abstract] [Full Text] [Related]

  • 10. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J, Lin S, Lin J, Tang L, Chen B, Zhang M, Zhang Y, Xu L, Chen Y, Xiao Y, Fang Y, Pan J.
    Oral Oncol; 2015 Mar 01; 51(3):254-9. PubMed ID: 25467207
    [Abstract] [Full Text] [Related]

  • 11. Nasopharyngeal carcinoma with paranasal sinus invasion: the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system.
    Tian L, Li YZ, Mo YX, Liu LZ, Xie CM, Liang XX, Gong X, Fan W.
    BMC Cancer; 2014 Nov 18; 14():832. PubMed ID: 25403714
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y, Pan J, Chen Y, Lin S, Chen Y, Zong J, Fang Y, Guo Q, Chen B, Tang L.
    Radiat Oncol; 2015 Sep 25; 10():204. PubMed ID: 26407897
    [Abstract] [Full Text] [Related]

  • 13. Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Wu L, Zhuo S, Zeng W, Liang S, Wang S, Cui C, Zhou J, Ruan G, Xu S, Wang L, Huang L, Liu L, Li H.
    Head Neck; 2019 Dec 25; 41(12):4088-4097. PubMed ID: 31518030
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of retropharyngeal lymph node metastasis laterality in nasopharyngeal carcinoma and a proposed modification to the UICC/AJCC N staging system.
    Huang L, Zhang Y, Liu Y, Li H, Wang S, Liang S, Zhou J, Cui C, Sun Y, Chen M, Xu S, Li J, Liu L.
    Radiother Oncol; 2019 Nov 25; 140():90-97. PubMed ID: 31195216
    [Abstract] [Full Text] [Related]

  • 15. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.
    Shi Q, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C.
    Radiat Oncol; 2014 Jan 06; 9():7. PubMed ID: 24393418
    [Abstract] [Full Text] [Related]

  • 16. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y, Hu XF, Wang Y, Chen HY, Yang L, Liu LZ, Cui CY, Liu DS, Liang SB.
    BMC Cancer; 2015 Apr 18; 15():305. PubMed ID: 25903652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paranasal Sinus Invasion Should Be Classified as T4 Disease in Advanced Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.
    Zhao Y, Zhou Q, Li N, Shen L, Li Z.
    Front Oncol; 2020 Apr 18; 10():01465. PubMed ID: 33240800
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.